Free US stock correlation to major indices and sector benchmarks for performance attribution analysis and return source identification. We help you understand how your portfolio moves relative to broader market benchmarks and identify return drivers. We provide correlation analysis, attribution breakdown, and benchmark comparison for comprehensive coverage. Understand performance drivers with our comprehensive correlation and attribution analysis tools for portfolio optimization.
As of April 16, 2026, The Oncology Institute Inc. (TOI) is trading at $3.54, posting an intraday gain of 3.21% during regular market hours. This analysis examines key technical price levels for TOI, recent market context for the specialty oncology care sector, and potential short-term price scenarios that market participants may monitor. No recently released quarterly earnings data is available for TOI at the time of writing, so current price action is largely being driven by technical flows and
The (TOI) Stock: Valuation Metrics (+3.21%) 2026-04-16 - Community Risk Signals
TOI - Stock Analysis
3493 Comments
1370 Likes
1
Lemonte
Insight Reader
2 hours ago
Really wish I had known before.
👍 48
Reply
2
Cina
New Visitor
5 hours ago
The market continues to consolidate, with short-term traders adjusting positions amid mixed signals.
👍 270
Reply
3
Rodolpho
Consistent User
1 day ago
Regret not noticing this sooner.
👍 173
Reply
4
Aylette
New Visitor
1 day ago
US stock market trends analysis and strategic positioning recommendations for investors seeking consistent performance. Our team continuously monitors economic indicators and market dynamics to anticipate major shifts before they occur.
👍 120
Reply
5
Katelinn
Expert Member
2 days ago
Investors are adapting to new information, resulting in choppy intraday price action.
👍 245
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.